Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
Despite the presence of antigens on the graft's vascular endothelium and the presence of antibodies in recipients' blood, clinical rejection does not always occur in ABO incompatible kidney transplantation. This phenomenon is called as accommodation. However, the mechanisms are undefined. We developed glycoconjugate microarray which is mimicked ABO blood group antigens expressed on human renal endothelium. In this study, we compared anti-A and anti-B antibodies reaction between red blood cells and renal endothelium. We found that antibodies production against donor blood group antigens of renal endothelium specifically inhibited after ABO incompatible kidney transplantation. This may be the mechanism of accommodation.
|